AXYS PHARMECUETICALS INC
POS AM, EX-23.1, 2000-07-10
PHARMACEUTICAL PREPARATIONS
Previous: AXYS PHARMECUETICALS INC, POS AM, EX-12.1, 2000-07-10
Next: AXYS PHARMECUETICALS INC, POS AM, EX-25.1, 2000-07-10



<PAGE>   1


                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3; Registration No. 333-35828) and related
Prospectus of Axys Pharmaceuticals, Inc. for the registration of $35,000,000
debt securities and warrants to purchase shares of its common stock and to the
incorporation by reference therein of our report dated February 18, 2000, with
respect to the consolidated financial statements of Axys Pharmaceuticals, Inc.
included in its Annual Report (Form 10-K) for the year ended December 31, 1999,
filed with the Securities and Exchange Commission.


                                                          Ernst & Young LLP

July 10, 2000
Palo Alto, California





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission